© 2019 Vasoptic Medical Inc.

1215 E. Fort Ave Suite 304
Baltimore, MD 21230

Comparison of tortuosity indices across software for retinopathy of prematurity (ROP)

September 1, 2016

ARVO Annual Meeting Abstract  |   September 2016

 

Purpose

 

Current methods used in screening for Retinopathy of Prematurity (ROP) are based on guidelines set forth by the International Committee for the Classification of Retinopathy of Prematurity in 2005. However, even amongst experienced pediatric ophthalmologists there is disagreement in the diagnosis of ROP suggesting subjectivity in these guidelines. ROP is a leading cause of childhood blindness and is rising in incidence in regions without readily available pediatric ophthalmologists thus establishing the need for more objective measures to evaluate ROP. Multiple software packages have been developed to automatically segment vessels and analyze tortuosity from fundus images. To our knowledge, their automated segmentation algorithms have not been compared on the same set of images. We performed a cross-sectional study comparing the tortuosity indices of three software packages with automated segmentation to manual segmentation.

 

 

Methods

 

16 retinal vessels from five premature infants were analyzed from photos by the RetCam3 (Clarity Medical Systems, Inc.). Visible vessels were divided into quadrants and compared. Automated Retinal Image Analyzer (ARIA) (Peter Bankhead), Computer Aided Image Analysis of the Retina (CAIAR) (University College London) and the investigational Automated Vessel Analysis Suite (AVAS) (Vasoptic Medical Inc.), were used to analyze the same images and the tortuosity indices were calculated for each of four quadrants. We used a linear regression analysis to compare the algorithms of software to manually segmented images.

 

Full Abstract

Share on Facebook
Share on Twitter
Please reload

Recent News

Vasoptic Medical impresses at ARVO 2017

May 30, 2017

Vasoptic Medical's $1.5 million cash infusion pushes it toward FDA approval

April 24, 2017

Title: Ophthalmic examination and disease management with multiple illumination modalities

Patent No. US9492083

Vasoptic receives another patent issuance from The United States Patent and Trademark Office (USPTO)

November 15, 2016

1/10
Please reload